Eris Lifesciences stated that its consolidated net profit increased 12 per cent to Rs 101 crore for the third quarter ended December 2021.
The company stated that the revenue stood at Rs 332 crore in the third quarter of the current fiscal as against Rs 310 crore in the year-ago period, Eris Lifesciences said.
''Our focus on building leadership brands in fast-growing therapies coupled with several patent expiration opportunities will enable us to sustain our growth trajectory,'' stated Eris Lifesciences Chairman & Managing Director Amit Bakshi.
(With inputs from PTI)
Uttar Pradesh: 42-Year-Old School Teacher Writes To PM Modi Praising LPG Delivery In State; Prime Minister Responds
Who Is Nadim Nadz? All About Mahhi Vij's 'Best Friend' Whom She Said 'I Love You' After Divorcing Jay Bhanushali
National Human Trafficking Awareness Day 2026: Everything About History, Significance, Theme & More
Haryana Police Constable Recruitment 2026: Registration Window For 5,500 Posts Opens; Check Selection Process Here
